COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study

The vaccine hit a major setback in December, when its developers announced that it did not appear to work well in older adults and that they would have to delay plans to test it in a Phase 3 trial, the crucial test that will assess the vaccine’s effectiveness.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sanofigsk’s-vaccine-said-to-produce-strong-immune-responsesmid-stage-study_15091641.html